276 related articles for article (PubMed ID: 27402010)
1. Positive regulation of the Candida albicans multidrug efflux pump Cdr1p function by phosphorylation of its N-terminal extension.
Tsao S; Weber S; Cameron C; Nehme D; Ahmadzadeh E; Raymond M
J Antimicrob Chemother; 2016 Nov; 71(11):3125-3134. PubMed ID: 27402010
[TBL] [Abstract][Full Text] [Related]
2. Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance.
Niimi M; Niimi K; Takano Y; Holmes AR; Fischer FJ; Uehara Y; Cannon RD
J Antimicrob Chemother; 2004 Dec; 54(6):999-1006. PubMed ID: 15486081
[TBL] [Abstract][Full Text] [Related]
3. ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates.
Holmes AR; Lin YH; Niimi K; Lamping E; Keniya M; Niimi M; Tanabe K; Monk BC; Cannon RD
Antimicrob Agents Chemother; 2008 Nov; 52(11):3851-62. PubMed ID: 18710914
[TBL] [Abstract][Full Text] [Related]
4. Functional expression of Candida albicans drug efflux pump Cdr1p in a Saccharomyces cerevisiae strain deficient in membrane transporters.
Nakamura K; Niimi M; Niimi K; Holmes AR; Yates JE; Decottignies A; Monk BC; Goffeau A; Cannon RD
Antimicrob Agents Chemother; 2001 Dec; 45(12):3366-74. PubMed ID: 11709310
[TBL] [Abstract][Full Text] [Related]
5. Rationally designed transmembrane peptide mimics of the multidrug transporter protein Cdr1 act as antagonists to selectively block drug efflux and chemosensitize azole-resistant clinical isolates of Candida albicans.
Maurya IK; Thota CK; Verma SD; Sharma J; Rawal MK; Ravikumar B; Sen S; Chauhan N; Lynn AM; Chauhan VS; Prasad R
J Biol Chem; 2013 Jun; 288(23):16775-16787. PubMed ID: 23592791
[TBL] [Abstract][Full Text] [Related]
6. Synthetic Organotellurium Compounds Sensitize Drug-Resistant Candida albicans Clinical Isolates to Fluconazole.
Reis de Sá LF; Toledo FT; Gonçalves AC; Sousa BA; Dos Santos AA; Brasil PF; Duarte da Silva VA; Tessis AC; Ramos JA; Carvalho MA; Lamping E; Ferreira-Pereira A
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821447
[TBL] [Abstract][Full Text] [Related]
7. ABC multidrug transporter Cdr1p of Candida albicans has divergent nucleotide-binding domains which display functional asymmetry.
Jha S; Dabas N; Karnani N; Saini P; Prasad R
FEMS Yeast Res; 2004 Oct; 5(1):63-72. PubMed ID: 15381123
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of fluconazole resistance in Candida albicans isolates from Japanese AIDS patients.
Maebashi K; Niimi M; Kudoh M; Fischer FJ; Makimura K; Niimi K; Piper RJ; Uchida K; Arisawa M; Cannon RD; Yamaguchi H
J Antimicrob Chemother; 2001 May; 47(5):527-36. PubMed ID: 11328762
[TBL] [Abstract][Full Text] [Related]
9. Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance.
Tsao S; Rahkhoodaee F; Raymond M
Antimicrob Agents Chemother; 2009 Apr; 53(4):1344-52. PubMed ID: 19223631
[TBL] [Abstract][Full Text] [Related]
10. Atomic modelling and systematic mutagenesis identify residues in multiple drug binding sites that are essential for drug resistance in the major Candida transporter Cdr1.
Nim S; Lobato LG; Moreno A; Chaptal V; Rawal MK; Falson P; Prasad R
Biochim Biophys Acta; 2016 Nov; 1858(11):2858-2870. PubMed ID: 27569110
[TBL] [Abstract][Full Text] [Related]
11. A Combination Fluorescence Assay Demonstrates Increased Efflux Pump Activity as a Resistance Mechanism in Azole-Resistant Vaginal Candida albicans Isolates.
Bhattacharya S; Sobel JD; White TC
Antimicrob Agents Chemother; 2016 Oct; 60(10):5858-66. PubMed ID: 27431223
[TBL] [Abstract][Full Text] [Related]
12. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene.
Sanglard D; Ischer F; Monod M; Bille J
Microbiology (Reading); 1997 Feb; 143 ( Pt 2)():405-416. PubMed ID: 9043118
[TBL] [Abstract][Full Text] [Related]
13. Lathyrol and epoxylathyrol derivatives: Modulation of Cdr1p and Mdr1p drug-efflux transporters of Candida albicans in Saccharomyces cerevisiae model.
Mónico A; Nim S; Duarte N; Rawal MK; Prasad R; Di Pietro A; Ferreira MU
Bioorg Med Chem; 2017 Jul; 25(13):3278-3284. PubMed ID: 28479022
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of N-terminal nucleotide binding domain (NBD-1) of a major ABC drug transporter Cdr1p of Candida albicans: uncommon but conserved Trp326 of Walker B is important for ATP binding.
Rai V; Shukla S; Jha S; Komath SS; Prasad R
Biochemistry; 2005 May; 44(17):6650-61. PubMed ID: 15850398
[TBL] [Abstract][Full Text] [Related]
15. Chimeras of the ABC drug transporter Cdr1p reveal functional indispensability of transmembrane domains and nucleotide-binding domains, but transmembrane segment 12 is replaceable with the corresponding homologous region of the non-drug transporter Cdr3p.
Saini P; Gaur NA; Prasad R
Microbiology (Reading); 2006 May; 152(Pt 5):1559-1573. PubMed ID: 16622073
[TBL] [Abstract][Full Text] [Related]
16. Engineering a Cysteine-Deficient Functional Candida albicans Cdr1 Molecule Reveals a Conserved Region at the Cytosolic Apex of ABCG Transporters Important for Correct Folding and Trafficking of Cdr1.
Madani G; Lamping E; Cannon RD
mSphere; 2021 Feb; 6(1):. PubMed ID: 33568458
[TBL] [Abstract][Full Text] [Related]
17. The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates.
Holmes AR; Keniya MV; Ivnitski-Steele I; Monk BC; Lamping E; Sklar LA; Cannon RD
Antimicrob Agents Chemother; 2012 Mar; 56(3):1508-15. PubMed ID: 22203607
[TBL] [Abstract][Full Text] [Related]
18. Newly identified motifs in Candida albicans Cdr1 protein nucleotide binding domains are pleiotropic drug resistance subfamily-specific and functionally asymmetric.
Rawal MK; Banerjee A; Shah AH; Khan MF; Sen S; Saxena AK; Monk BC; Cannon RD; Bhatnagar R; Mondal AK; Prasad R
Sci Rep; 2016 Jun; 6():27132. PubMed ID: 27251950
[TBL] [Abstract][Full Text] [Related]
19. Substitution of threonine-1351 in the multidrug transporter Cdr1p of Candida albicans results in hypersusceptibility to antifungal agents and threonine-1351 is essential for synergic effects of calcineurin inhibitor FK520.
Shukla S; Ambudkar SV; Prasad R
J Antimicrob Chemother; 2004 Jul; 54(1):38-45. PubMed ID: 15190023
[TBL] [Abstract][Full Text] [Related]
20. Inhibitor-Resistant Mutants Give Important Insights into Candida albicans ABC Transporter Cdr1 Substrate Specificity and Help Elucidate Efflux Pump Inhibition.
Niimi M; Niimi K; Tanabe K; Cannon RD; Lamping E
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0174821. PubMed ID: 34780272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
